ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising advancements across various health-related and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, much more reliable substitute for therapeutic use